ReviewKorean journal of radiology2025
Contrast-Enhanced Mammography: Advances, Challenges, and Case-Based Insights.
Review in Korean journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Time to reconsider the role of contrast-enhanced mammography in work-up after screening?European radiology · 2026Article
- Contrast-Enhanced Mammography for High-Risk Women: Implications for Latin America and Developing Regions.Korean journal of radiology · 2026Article
- Effectiveness of Contrast-Enhanced Spectral Mammography Following Contrast-Enhanced Computed Tomography in Breast Cancer Diagnosis.Diagnostics (Basel, Switzerland) · 2026Article
- Beyond the lung: recognizing incidental breast lesions on chest computed tomography.Translational cancer research · 2026Review
- Diagnostic value of contrast-enhanced spectral mammography for breast lesions: qualitative and quantitative analyses.Quantitative imaging in medicine and surgery · 2026Article
- Evolving Role of Contrast-Enhanced Mammography-Guided Biopsy: Clinical Value and Limitations.Korean journal of radiology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-enhanced mammography (CEM) has increasingly been established as a valuable tool in breast imaging that enhances lesion detection and characterization by combining functional and anatomical information. This review highlights the recent key advances in CEM technology, explores its expanding clinical applications, and discusses the common interpretation pitfalls and current limitations. Instead of offering a comprehensive overview, this review focuses on providing a case-based perspective on emerging applications and how CEM can be efficiently incorporated into clinical practice. Through illustrative case examples, we offer practical insights into optimizing breast imaging strategies and demonstrate how CEM can effectively complement other imaging modalities in both routine practice and complex diagnostic scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.